nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Lisinopril—dilated cardiomyopathy	0.293	0.532	CbGbCtD
Scopolamine—ABCB1—Spironolactone—dilated cardiomyopathy	0.258	0.468	CbGbCtD
Scopolamine—Application site pain—Furosemide—dilated cardiomyopathy	0.0151	0.0633	CcSEcCtD
Scopolamine—Ipratropium bromide—SLC22A5—dilated cardiomyopathy	0.00942	1	CrCbGaD
Scopolamine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00768	0.0321	CcSEcCtD
Scopolamine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00684	0.0286	CcSEcCtD
Scopolamine—Thirst—Furosemide—dilated cardiomyopathy	0.00507	0.0212	CcSEcCtD
Scopolamine—Photophobia—Lisinopril—dilated cardiomyopathy	0.00469	0.0196	CcSEcCtD
Scopolamine—Irritability—Furosemide—dilated cardiomyopathy	0.00461	0.0193	CcSEcCtD
Scopolamine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00459	0.0192	CcSEcCtD
Scopolamine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0044	0.0184	CcSEcCtD
Scopolamine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00426	0.0178	CcSEcCtD
Scopolamine—Eczema—Lisinopril—dilated cardiomyopathy	0.00403	0.0169	CcSEcCtD
Scopolamine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00388	0.0162	CcSEcCtD
Scopolamine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00372	0.0156	CcSEcCtD
Scopolamine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00359	0.015	CcSEcCtD
Scopolamine—Sweating—Furosemide—dilated cardiomyopathy	0.00357	0.0149	CcSEcCtD
Scopolamine—Irritability—Lisinopril—dilated cardiomyopathy	0.00346	0.0145	CcSEcCtD
Scopolamine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00345	0.0144	CcSEcCtD
Scopolamine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.0033	0.0138	CcSEcCtD
Scopolamine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00327	0.0137	CcSEcCtD
Scopolamine—Visual impairment—Furosemide—dilated cardiomyopathy	0.00322	0.0135	CcSEcCtD
Scopolamine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00312	0.0131	CcSEcCtD
Scopolamine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00309	0.0129	CcSEcCtD
Scopolamine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00298	0.0125	CcSEcCtD
Scopolamine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00293	0.0123	CcSEcCtD
Scopolamine—Erythema—Furosemide—dilated cardiomyopathy	0.00291	0.0122	CcSEcCtD
Scopolamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00288	0.0121	CcSEcCtD
Scopolamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00277	0.0116	CcSEcCtD
Scopolamine—Rash—Spironolactone—dilated cardiomyopathy	0.00275	0.0115	CcSEcCtD
Scopolamine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00275	0.0115	CcSEcCtD
Scopolamine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00274	0.0115	CcSEcCtD
Scopolamine—Headache—Spironolactone—dilated cardiomyopathy	0.00273	0.0114	CcSEcCtD
Scopolamine—Sweating—Lisinopril—dilated cardiomyopathy	0.00268	0.0112	CcSEcCtD
Scopolamine—Agitation—Furosemide—dilated cardiomyopathy	0.00267	0.0112	CcSEcCtD
Scopolamine—Vertigo—Furosemide—dilated cardiomyopathy	0.00261	0.0109	CcSEcCtD
Scopolamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00259	0.0108	CcSEcCtD
Scopolamine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00255	0.0107	CcSEcCtD
Scopolamine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00249	0.0104	CcSEcCtD
Scopolamine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00249	0.0104	CcSEcCtD
Scopolamine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00248	0.0104	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00246	0.0103	CcSEcCtD
Scopolamine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00246	0.0103	CcSEcCtD
Scopolamine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00242	0.0101	CcSEcCtD
Scopolamine—Confusional state—Furosemide—dilated cardiomyopathy	0.00239	0.01	CcSEcCtD
Scopolamine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00233	0.00974	CcSEcCtD
Scopolamine—Flushing—Lisinopril—dilated cardiomyopathy	0.00233	0.00974	CcSEcCtD
Scopolamine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00231	0.00965	CcSEcCtD
Scopolamine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00229	0.0096	CcSEcCtD
Scopolamine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00224	0.00937	CcSEcCtD
Scopolamine—Hypotension—Furosemide—dilated cardiomyopathy	0.00222	0.00928	CcSEcCtD
Scopolamine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.0022	0.00919	CcSEcCtD
Scopolamine—Erythema—Lisinopril—dilated cardiomyopathy	0.00218	0.00913	CcSEcCtD
Scopolamine—Somnolence—Furosemide—dilated cardiomyopathy	0.00211	0.00883	CcSEcCtD
Scopolamine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00206	0.00861	CcSEcCtD
Scopolamine—Fatigue—Furosemide—dilated cardiomyopathy	0.00205	0.00856	CcSEcCtD
Scopolamine—Tremor—Lisinopril—dilated cardiomyopathy	0.00204	0.00856	CcSEcCtD
Scopolamine—Pain—Furosemide—dilated cardiomyopathy	0.00203	0.00849	CcSEcCtD
Scopolamine—Constipation—Furosemide—dilated cardiomyopathy	0.00203	0.00849	CcSEcCtD
Scopolamine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00196	0.0082	CcSEcCtD
Scopolamine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00196	0.00819	CcSEcCtD
Scopolamine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00188	0.00785	CcSEcCtD
Scopolamine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00188	0.00785	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00184	0.00772	CcSEcCtD
Scopolamine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00182	0.0076	CcSEcCtD
Scopolamine—Confusional state—Lisinopril—dilated cardiomyopathy	0.0018	0.00751	CcSEcCtD
Scopolamine—Oedema—Lisinopril—dilated cardiomyopathy	0.00178	0.00745	CcSEcCtD
Scopolamine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00174	0.00727	CcSEcCtD
Scopolamine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00173	0.00724	CcSEcCtD
Scopolamine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00172	0.0072	CcSEcCtD
Scopolamine—Asthenia—Furosemide—dilated cardiomyopathy	0.0017	0.00713	CcSEcCtD
Scopolamine—Pruritus—Furosemide—dilated cardiomyopathy	0.00168	0.00703	CcSEcCtD
Scopolamine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00166	0.00696	CcSEcCtD
Scopolamine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00158	0.00663	CcSEcCtD
Scopolamine—Dizziness—Furosemide—dilated cardiomyopathy	0.00157	0.00657	CcSEcCtD
Scopolamine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00154	0.00643	CcSEcCtD
Scopolamine—Pain—Lisinopril—dilated cardiomyopathy	0.00152	0.00637	CcSEcCtD
Scopolamine—Constipation—Lisinopril—dilated cardiomyopathy	0.00152	0.00637	CcSEcCtD
Scopolamine—Vomiting—Furosemide—dilated cardiomyopathy	0.00151	0.00632	CcSEcCtD
Scopolamine—Rash—Furosemide—dilated cardiomyopathy	0.0015	0.00626	CcSEcCtD
Scopolamine—Dermatitis—Furosemide—dilated cardiomyopathy	0.0015	0.00626	CcSEcCtD
Scopolamine—Headache—Furosemide—dilated cardiomyopathy	0.00149	0.00622	CcSEcCtD
Scopolamine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00147	0.00614	CcSEcCtD
Scopolamine—Nausea—Furosemide—dilated cardiomyopathy	0.00141	0.0059	CcSEcCtD
Scopolamine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00141	0.00589	CcSEcCtD
Scopolamine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00141	0.00589	CcSEcCtD
Scopolamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00128	0.00535	CcSEcCtD
Scopolamine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00126	0.00527	CcSEcCtD
Scopolamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00118	0.00493	CcSEcCtD
Scopolamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00113	0.00474	CcSEcCtD
Scopolamine—Rash—Lisinopril—dilated cardiomyopathy	0.00112	0.0047	CcSEcCtD
Scopolamine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00112	0.00469	CcSEcCtD
Scopolamine—Headache—Lisinopril—dilated cardiomyopathy	0.00112	0.00467	CcSEcCtD
Scopolamine—Nausea—Lisinopril—dilated cardiomyopathy	0.00106	0.00443	CcSEcCtD
Scopolamine—CHRM5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000434	0.00217	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000431	0.00215	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000415	0.00207	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000413	0.00206	CbGpPWpGaD
Scopolamine—SI—Metabolism—AGT—dilated cardiomyopathy	0.00041	0.00205	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000409	0.00204	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000401	0.00201	CbGpPWpGaD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0004	0.002	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0004	0.002	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000399	0.00199	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000396	0.00198	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000395	0.00197	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000387	0.00193	CbGpPWpGaD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00038	0.0019	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000378	0.00189	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000375	0.00187	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000371	0.00185	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000367	0.00184	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000367	0.00183	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000364	0.00182	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000363	0.00181	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000358	0.00179	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000352	0.00176	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000343	0.00171	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000343	0.00171	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000342	0.00171	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00034	0.0017	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00034	0.0017	CbGpPWpGaD
Scopolamine—SI—Disease—RAF1—dilated cardiomyopathy	0.000339	0.0017	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000338	0.00169	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000338	0.00169	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000338	0.00169	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000335	0.00167	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000335	0.00167	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000328	0.00164	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000326	0.00163	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000325	0.00163	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000325	0.00162	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000324	0.00162	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000321	0.0016	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000321	0.0016	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000316	0.00158	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000316	0.00158	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000315	0.00157	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000312	0.00156	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000308	0.00154	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.000308	0.00154	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000308	0.00154	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000308	0.00154	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000306	0.00153	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000305	0.00152	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000303	0.00152	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000302	0.00151	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000302	0.00151	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.0003	0.0015	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000299	0.0015	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000295	0.00148	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000286	0.00143	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000285	0.00142	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000285	0.00142	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.000279	0.00139	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000273	0.00136	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000273	0.00136	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000272	0.00136	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000265	0.00132	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000261	0.0013	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000261	0.0013	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00026	0.0013	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000258	0.00129	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000258	0.00129	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000258	0.00129	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000256	0.00128	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000253	0.00127	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000251	0.00125	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000248	0.00124	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000247	0.00124	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000247	0.00124	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000247	0.00123	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000245	0.00123	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000245	0.00122	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000242	0.00121	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000241	0.00121	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000241	0.0012	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00024	0.0012	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000238	0.00119	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000237	0.00118	CbGpPWpGaD
Scopolamine—SI—Disease—EGFR—dilated cardiomyopathy	0.000233	0.00116	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000233	0.00116	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00023	0.00115	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000226	0.00113	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000225	0.00113	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000223	0.00111	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00022	0.0011	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000219	0.00109	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00021	0.00105	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000208	0.00104	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000208	0.00104	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000208	0.00104	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000208	0.00104	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000207	0.00104	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000205	0.00103	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000199	0.000993	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000199	0.000993	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000196	0.000977	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000192	0.000959	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000192	0.000959	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000191	0.000956	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000191	0.000956	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00019	0.000951	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000189	0.000947	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000189	0.000947	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000189	0.000942	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000188	0.000942	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000184	0.000918	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000183	0.000915	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000181	0.000906	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000181	0.000902	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000178	0.000891	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000178	0.000889	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000177	0.000884	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000176	0.00088	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000174	0.000871	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000174	0.000871	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000174	0.000868	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000174	0.000868	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000173	0.000863	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000172	0.000861	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000172	0.00086	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000172	0.00086	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000172	0.000859	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000171	0.000852	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000165	0.000823	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000162	0.000809	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000161	0.000807	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000161	0.000805	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00016	0.000799	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000157	0.000786	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000157	0.000784	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000156	0.000781	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000155	0.000775	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000155	0.000774	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000155	0.000772	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000154	0.000771	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000154	0.000769	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000153	0.000763	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000153	0.000763	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000148	0.000737	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000147	0.000737	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000147	0.000735	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000146	0.000731	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000146	0.000731	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000146	0.000731	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000146	0.000728	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000142	0.000709	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00014	0.0007	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00014	0.000699	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00014	0.000699	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00014	0.000697	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000138	0.00069	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000137	0.000687	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000136	0.000679	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000134	0.00067	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000134	0.000669	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000134	0.000667	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000132	0.000661	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000132	0.000658	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000127	0.000635	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000127	0.000633	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000125	0.000627	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000117	0.000587	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000116	0.000579	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000116	0.000577	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000114	0.000572	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000112	0.000562	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000111	0.000556	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000109	0.000543	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000108	0.000541	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000108	0.000539	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000107	0.000536	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000107	0.000533	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000104	0.000519	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000104	0.000517	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000103	0.000514	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000103	0.000514	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000103	0.000513	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000103	0.000513	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000103	0.000513	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000102	0.000512	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000102	0.000508	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000102	0.000508	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.87e-05	0.000493	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.84e-05	0.000492	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.74e-05	0.000487	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.7e-05	0.000485	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.57e-05	0.000478	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.57e-05	0.000478	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.54e-05	0.000477	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.45e-05	0.000472	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	9.43e-05	0.000471	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	9.4e-05	0.00047	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	9.31e-05	0.000465	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.29e-05	0.000464	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.27e-05	0.000463	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.24e-05	0.000462	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.16e-05	0.000458	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.15e-05	0.000457	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	8.65e-05	0.000432	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	8.28e-05	0.000414	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	8.26e-05	0.000413	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.92e-05	0.000396	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	7.91e-05	0.000395	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.89e-05	0.000394	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.81e-05	0.00039	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	7.57e-05	0.000378	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.51e-05	0.000375	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.49e-05	0.000374	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.41e-05	0.00037	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CD36—dilated cardiomyopathy	7.37e-05	0.000369	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.66e-05	0.000333	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AGT—dilated cardiomyopathy	6.64e-05	0.000332	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.54e-05	0.000327	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.52e-05	0.000326	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.46e-05	0.000323	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.45e-05	0.000322	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.43e-05	0.000321	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.37e-05	0.000318	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.37e-05	0.000318	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.24e-05	0.000312	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.83e-05	0.000291	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	5.81e-05	0.00029	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	5.75e-05	0.000288	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	5.73e-05	0.000286	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	5.57e-05	0.000278	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	5.55e-05	0.000277	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	5.5e-05	0.000275	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	5.49e-05	0.000274	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.8e-05	0.00024	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.68e-05	0.000234	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.49e-05	0.000224	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.47e-05	0.000224	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.43e-05	0.000221	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	4.21e-05	0.000211	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	3.93e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.87e-05	0.000193	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	3.85e-05	0.000193	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	3.82e-05	0.000191	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	3.76e-05	0.000188	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.65e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	2.64e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.62e-05	0.000131	CbGpPWpGaD
